Search
for
Sort by
Research 241–270 of 280
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- Correlation between Androgenetic Alopecia and Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection in China
- Growth retardation and hair loss in transgenic mice overexpressing human H-ferritin gene
- Identification of SLC40A1, LCN2, CREB5, and SLC7A11 as ferroptosis-related biomarkers in alopecia areata through machine learning
- Acute and Chronic Telogen Effluvium
- Acute and Chronic Telogen Effluvium
- The impact of individual lifestyle and status on the acquisition of COVID-19: A case—Control study
- A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
- The Percentage of Free PSA and Urinary Markers Distinguish Prostate Cancer from Benign Hyperplasia and Contribute to a More Accurate Indication for Prostate Biopsy
- COVID-19 Severity and Androgen Receptor Polymorphism
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
- A Concise Review of Organoid Tissue Engineering: Regenerative Applications and Precision Medicine
- Diabetes Mellitus and Prostate Cancer Risk—A Systematic Review and Meta-Analysis
- The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants
- Extrapulmonary manifestations of coronavirus disease (COVID-19): current status (a literature review)
- Global Impact of Coronavirus Disease 2019 (COVID-19)
- Trends in the global organoid technology and industry: from organogenesis in a dish to the commercialization of organoids
- The 100 most cited articles in androgenetic alopecia: A bibliometric analysis
- Repurposed Drugs: Current Trends in Drug Discovery
- Photobiostimulation Therapy (PBST) and Pulsed Electromagnetic Field Therapy (PEMF) in Hair Loss Treatment: Multicentric, Retrospective, Case–Control Study
- A comprehensive review of etiology, pathophysiologyepidemiology, and management of hair loss and its correlation with COVID-19
- Structural perspectives on the androgen receptor, the elusive shape-shifter
- FEATURES OF THE DEVELOPMENT OF ACUTE DIFFUSE TELOGEN EFFLUVIUM IN PATIENTS WITH POST-COVID SYNDROME
- Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- Self-Reported Hair Loss Following COVID-19: An Observational Study
- Потеря волос, ассоциированная с COVID‑19: проблема и пути решения